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Abstract
Background: Histamine-metabolizing enzymes (N-methyltransferase and amiloride binding protein 1) are
responsible for histamine degradation, a biogenic amine involved in allergic inflammation. Genetic variants of
HNMT and ABP1 genes were found to be associated with altered enzyme activity. We hypothesized that alleles
leading to decreased enzyme activity and, therefore, decreased inactivation of histamine may be responsible for
altered susceptibility to asthma.
Methods: The aim of this study was to analyze polymorphisms within the HNMT and ABP1 genes in the group of
149 asthmatic children and in the group of 156 healthy children. The genetic analysis involved four polymorphisms
of the HNMT gene: rs2071048 (-1637T/C), rs11569723 (-411C/T), rs1801105 (Thr105Ile = 314C/T) and rs1050891
(1097A/T) and rs1049793 (His645Asp) polymorphism for ABP1 gene. Genotyping was performed with use of PCR-
RFLP. Statistical analysis was performed using Statistica software; linkage disequilibrium analysis was done with use
of Haploview software.
Results: We found an association of TT genotype and T allele of Thr105Ile polymorphism of HNMT gene with
asthma. For other polymorphisms for HNMT and ABP1 genes, we have not observed relationship with asthma
although the statistical power for some SNPs might not have been sufficient to detect an association. In linkage
disequilibrium analysis, moderate linkage was found between -1637C/T and -411C/T polymorphisms of HNMT gene.
However, no significant differences in haplotype frequencies were found between the group of the patients and
the control group.
Conclusions: Our results indicate modifying influence of histamine N-methyltransferase functional polymorphism
on the risk of asthma. The other HNMT polymorphisms and ABP1 functional polymorphism seem unlikely to affect
the risk of asthma.
Background
Histamine is a preformed mediator released during mast
cell degranulation that plays a key role in the develop-
ment of allergic inflammation and, subsequently, leads
to atopic diseases such as bronchial asthma. Released
histamine is metabolized by two enzymes: N-methyl-
transferase (HNMT) and diamine oxidase (amiloride
binding protein 1, ABP1).
N-methylation catalyzed by cytosolic HNMT enzyme
is the primary pathway for histamine bio-transformation
in bronchial epithelium [1]. HNMT gene is located on
the chromosome 2q22.1 and within the gene region,
several polymorphisms have been identified. A common
C314T polymorphism leading to Thr105Ile substitution
was discovered by Preuss et al. [2] and it was found that
less common T allele (encoding Ile) was associated with
decreased HNMT enzyme activity [2,3]. Other func-
tional SNP T939C (rs1050891) is located in the 3’
untranslated region of the gene and correlates with
HNMT activity, as Kim et al. [4] showed that the C
allele correlated with increased stability of transcripts
containing the HNMT 3’ untranslated region and
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morphisms are in strong linkage disequilibrium. Other
SNPs from the 5’-flanking region (-1637T/C, -463T/C,
-411C/T) as well as 3’UTR (939A/G and 1097A/T) of
HNMT gene have been also identified [5], however their
functionality has not been elucidated yet.
ABP1 enzyme is mainly expressed in kidney, colon,
placenta, thymus and seminal vesicles and plays role in
the inactivation of extracellular histamine [6-8]. The
ABP1 gene has been localized on chromosome the
7q34-36 and within the gene region several polymorph-
isms have been identified. Among these, His645Asp sub-
stitution (rs1049793) was found to be functional and
was associated with significant decrease in the serum
enzyme activity in vivo [9]. Other non-synonymous
SNPs that were suspected to influence enzyme activity
or kinetics based on UniProt database include Thr16Met
(rs10156191) and Ser332Phe (rs1049742). Although they
were found to slightly alter enzyme kinetics by increas-
ing the Km of the ABP1 enzyme, no significant changes
were observed in relation to the genotypes of those two
SNPs [9].
The importance of genetic variation of genes related
to histamine (including histamine-metabolizing enzymes
HNMT and ABP1) was widely discussed in recent
review on histamine pharmacogenomics where authors
summarized association studies of those genes and their
involvement in diverse diseases, including allergic dis-
eases and asthma [10].
We hypothesized that polymorphisms within the
HNMT and ABP1 genes responsible for individual varia-
tion of histamine metabolism might contribute to the
pathophysiology of asthma. The aim of our study was to
analyze a relationship between the polymorphisms of
two genes encoding histamine metabolizing enzymes
(HNMT and ABP1) with the predisposition to asthma in
the Polish population of pediatric patients.
Methods
Patients’ group
The study was performed on Polish sample of 149 asth-
matic patients of Caucasian origin in age from 6 to 18
years old (86 boys with a mean age of 11.8 years, SD =
3.1; 63 girls with a mean age of 12.0 years, SD = 3.8).
Patients were recruited from inpatients from Wielko-
polska region, considered as ethnically homogenous
[11], and were treated for asthma in the Department of
Pediatric Pulmonology, Allergy and Clinical Immunol-
ogy of Poznan University of Medical Sciences. Asthma
diagnosis was made according to GINA recommenda-
tion, based on clinical asthma symptoms and lung func-
tion test (bronchodilator responsiveness, exercise
induced hyperresponsiveness); bronchodilator response
was assessed 20 minutes after administration of 200
mcg of Salbutamol MDI via a holding chamber (Volu-
matic) and a ≥ 12% increase in FEV1 was diagnostic;
bronchial hyperresponsiveness was assessed by exercise
test using 6 min. run on the treadmill and a post exer-
cise fall in FEV1 of ≥ 15% was considered positive.
Clinical diagnosis of atopy depended on current or
past symptoms of atopic dermatitis, allergic rhinocon-
junctivitis (seasonal or perennial) or food allergy. Atopy
was confirmed when children fulfilled one of the follow-
ing criteria: total IgE level higher than the upper normal
limits for age; positive skin prick test to at least one
aero-allergen (Dermatophagoides pteronyssinus, Derma-
tophagoides farinae, cat, dog, feathers, Alternaria alter-
nata, Cladosporium herbarum; pollen: grass mix, rye,
birch pollen, alder, hazel – Allergopharma, Germany).
Any reaction with mean wheal diameter at least 3 mm
greater than negative control was regarded positive and
defined atopy. Total serum IgE level was measured by a
fluoroimmunossay with Pharmacia UniCap 100 System®
(Pharmacia, Uppsala, Sweden) following manufacturer’s
instruction. The upper limits of normal range for total
IgE was age-dependent (70 kU/l for 6 yr children; 79
KU/L for 7 yr children, 89 KU/L for 8 yr children, 98
KU/L for 9 yr children, 107.0 KU/L for children of 10
years and older).
Control group
Control group consisted of 156 healthy subjects of
Caucasian origin (76 boys with a mean age of 10.8
years, SD = 2.7; 80 girls with a mean age of 10.3 years,
SD = 2.9). Control subjects were also recruited from the
same geographic region (Wielkopolska) from the group
of carefully chosen volunteers without asthma and
allergy symptoms. Any allergic diseases or asthma were
excluded based on clinical examination, history, spiro-
metry and exhaled NO measurement.
All participants as well as their parents have given
written informed consent. Local ethics committee
accepted the project. Study was performed in compli-
ance with the Code of Ethics of the World Medical
Association (Declaration of Helsinki).
Genotyping
The DNA was extracted from 10 ml of EDTA anticoa-
gulated whole blood using the salting out method [12].
The HNMT and ABP1 polymorphisms were analyzed by
PCR-RFLP method. The conditions of PCR-RFLP and
sequences of the primers for the HNMT polymorphisms
(-1637C/T, -411C/T, 314C/T and 1097A/T) were used
as described previously [13]. For ABP1 His645Asp poly-
morphism, the genotyping was performed according to
conditions described by Garcia-Martin et al. [14].
The uncut PCR products for HNMT polymorphisms
were digested twice to confirm the results. The quality
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randomly chosen samples from both groups) and the
concordance between two assays was 100%. DNA sam-
ples were randomly plated during genotyping and reac-
tions were performed without knowing the clinical
outcome of the patient.
Statistical analysis
The Pearson’s chi-square (c
2) test and Fisher’s exact test
were used to test differences in the genotypic and allelic
(respectively) distribution in case control. The alpha
level < 0.05 was considered significant. Calculations
were performed using the STATISTICA version 8.0
software. The association between HNMT 314 C/T and
ABP1 polymorphisms and the risk of developing asthma
was estimated by an odds ratio (OR) with a 95% confi-
dence interval (CI) using demo of GraphPad InStat 3
programme. Concordance with Hardy-Weinberg law
was performed using “Utility Programs For Analysis Of
Genetic Linkage” application (Copyright
© 1988 J. Ott).
We also performed linkage disequilibrium analysis of
the analyzed polymorphisms of HNMT gene using free
online software Haploview version 4.1 from the website:
http://www.broadinstitute.org/haploview[15]. Power cal-
culations were done in Quanto v.1.2.3 with OR values
between 1.1 and 2.5 for two-sided associations were for
HNMT polymorphisms: 10% for 1637, 82% for 314,
9.7% for 411, 23.8% for 1097 and 23.9% for ABP1
polymorphism.
Results
Genotype distributions for all studied polymorphisms in
the HNMT and ABP1 genes were in concordance with
Hardy-Weinberg law in both cases and control subjects,
except -1637C/T HNMT polymorphism in the control
g r o u p( p=0 . 0 2 6 )a n dABP1 His645Asp polymorphism
in the group of asthmatic patients (p = 0.046).
In the analysis of genotype distribution we observed
significant differences for 314C/T polymorphism, with
TT genotype significantly more frequent in the group of
asthmatic children in comparison to the control group
(Table 1). When we analyzed our group according to
gender, we also observed the association of TT genotype
in the group of asthmatic boys compared to the healthy
boys (p = 0.003). For the other three polymorphisms
(-1637C/T, -411C/T and 1097A/T) we did not observe
significant differences in genotype distribution between
the group of asthmatic patients and the control group
(Table 1).
Comparison of allele frequencies revealed that T allele
of 314C/T polymorphism was significantly more fre-
quent in the group of asthmatic patients as compared to
the control group (p = 0.048). This allele was also statis-
tically more frequent in the group of asthmatic boys
(p = 0.009), but not in the group of asthmatic girls in
comparison to the control subjects, male and female,
respectively. The OR (95%CI) for carriers of T allele
(Ile) was 1.88 (1.09-3.25) for patients with asthma. For
the other three polymorphisms of HNMT gene we have
not found any significant differences between cases and
controls. The positive result for 314C/T polymorphism
was confirmed further by genotyping additional group
of our group of asthmatic (n = 174 altogether) and con-
trol children (n = 211 altogether) of the same Caucasian
origin and the association was confirmed (p = 0.015 for
genotypes; p = 0.011 for alleles, OR = 1.745, 95%
CI:1.151-2.646).
For the ABP1 gene His645Asp polymorphism, no sig-
nificant differences were in genotype distribution
Table 1 Genotype distributions and allele frequencies of
four HNMT polymorphisms and one ABP1 polymorphism
for asthmatic patients versus control group (figures in
parentheses indicate percentages)
Gene Polymorphism Asthma Control P value
1637 N = 139 N = 137 0.352
genotypes TT 38 (27.3) 41 (29.9)
CT 75 (53.9) 79 (57.7)
CC 26 (18.8) 17 (12.4)
alelles T 151 (54.3) 161 (58.7) 0.303
C 127 (45.7) 113 (41.3)
314 N = 149 N = 147 0.042*
genotypes CC 99 (66.4) 119 (80.9)
CT 43 (28.9) 26 (17.7)
TT 7 (4.7) 2 (1.4)
alelles C 241 (80.9) 264 (89.8) 0.048*
T 45 (19.1) 30 (10.2)
HNMT 411 N = 146 N = 156 0.720
genotypes TT 7 (4.8) 5 (3.2)
CT 43 (29.4) 50 (32.1)
CC 96 (65.8) 101 (64.7)
alelles T 57 (19.5) 60 (19.2) 1.000
C 235 (80.5) 252 (80.8)
1097 N = 146 N = 156 0.977
genotypes CC 90 (61.6) 95 (60.9)
CG 51 (34.9) 55 (35.3)
GG 5 (3.4) 6 (3.8)
alelles C 231 (79.1) 245 (78.5) 0.920
G 61 (20.9) 67 (21.5)
ABP1 His645Asp N = 146 N = 156 0.530
genotypes TT 75 (51.4) 79 (54.1)
AT 52 (35.6) 54 (37.0)
AA 19 (13.0) 13 (8.9)
alelles T 202 (69.2) 212 (72.6) 0.412
A 90 (30.8) 80 (27.4)
* indicates significance: c
2 = 6.302, df = 2.
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asthmatic patients and the control group. The OR (95%
CI) for carriers of ABP1 G variant (Asp) was 1.16 (0.70-
1.76) in patients with asthma. No gender-specific differ-
ences were observed in our sample for the studied ABP1
polymorphism. Data were shown in table 1.
We have also performed analysis of the HNMT and
ABP1 SNPs in regard to asthma-related phenotypes
such as asthma severity, total IgE level, FEV1 and exNO
measurement, however, no significant associations with
any of the studied polymorphisms were observed (data
not shown).
In linkage disequilibrium analysis for HNMT poly-
morphisms, we found suggestive evidence for linkage
between -1637C/T and -411C/T polymorphisms (D’ =
0.95; 95%CI = 0.86-0.99; LOD = 22.5; r
2 = 0.295). How-
ever, comparing haplotype frequencies in this block, no
significant differences were observed between the asth-
matic patients and the control subjects (see table 2).
Based on the four gamete rule (Wang et al.2002) that
assumes linkage if the 4
th gamete is observed at fre-
quency > 0.01, we found such a linkage between -411C/
T and 314C/T polymorphisms (D’ = 1.0; LOD = 2.01;
r
2 = 0.0.035). When we compared haplotype frequencies
within this block, we observed that CT haplotype
(C allele of -411 polymorphism and T allele of 314 poly-
morphism) was significantly more frequent in the group
of asthmatic patients in comparison to the control sub-
jects (p = 0.0046). However, this linkage seems unlikely,
considering the distance between those two markers (37
kb) and observed association of CT haplotype with
asthma probably depends only on the association of
314C/T polymorphism in our group.
As both HNMT and ABP1 enzymes are involved in
histamine metabolism, we analyzed both functional var-
iants together (Thr105Ile of HNMT gene and
His645Asp of ABP1 gene) to check if the two allelic var-
iants responsible for reduced activity of both enzymes
are more frequently observed in asthmatic patients. We
have not found any statistically significant differences in
frequencies of HNMT and ABP1 allelic variants combi-
nations between the asthmatic patients and the control
subjects (data not presented).
Discussion
The main finding of this study is an association of
314C/T polymorphism of HNMT gene with asthma in
the Polish population of pediatric patients which may
confirm that impaired histamine metabolism caused by
reduced activity of HNMT is involved in asthma
pathogenesis.
This common polymorphism responsible for
Thr105Ile substitution was discovered by Preuss et al.
[2] and it was found that less common T allele (encod-
ing Ile) was associated with decreased HNMT enzyme
activity [2,3]. In our study, we found this T allele asso-
ciated with asthma, which is consistent with the findings
by Yan et al. [16], but in contrast to the results obtained
by the others [17-19]. In addition, this SNP was also
associated with higher risk of developing atopic dermati-
tis [20]. This most extensively studied polymorphism of
HNMT gene was also involved in other disorders asso-
ciated with altered histamine metabolism such as
inflammatory bowel disease, neuronal degeneration and
alcoholism as summarized by Garcia-Martin et al. [10].
Many inconsistent findings regarding this SNP through-
out the different populations analyzed, were, in part,
due to insufficient power of those studies (including the
present one) to detect an association. Therefore, we
aimed to combine the frequencies for particular geno-
types and alleles from different populations to see if
increasing sample size could be more sensitive in finding
association by increasing statistical power. We have
taken together the data from the genotype and allele fre-
quencies from the other papers with both positive ([16],
present study) and negative results [17-19,21] for asth-
matics and control group (regardless the ethnicity) and
we found that TT genotype and T allele were signifi-
cantly more frequent among asthmatic patients
(Table 3). Taking into account the relatively low MAF
of this SNP, we have demonstrated that increasing the
s a m p l es i z em a yp r o d u c em o r er e l i a b l ea n dc o n s i s t e n t
results as the power calculation for the combined sam-
ple was sufficient (78.3%) to detect an association.
Table 2 Comparison of haplotype frequencies for -1637
and -411 polymorphisms between asthmatics and control
group
Haplotype Frequency Case: control ratios c
2 p
TC 0.564 0.540 : 0.586 1.309 0.2525
CC 0.242 0.265 : 0.222 1.516 0.2183
CT 0.189 0.187 : 0.190 0.0090 0.9236
Table 3 Genotype distributions and allele frequencies for
314C/T polymorphism of HNMT gene from five
association studies in asthma (asthmatic patients vs.
control group)
Asthma (n = 1049) Control group (n = 1242) P value
CC 806 (76.8) 1011 (81.4) 0.007*
CT 221 (21.1) 219 (17.6)
TT 22 (2.1) 12 (1.0)
C 1833 (87.4) 2241 (90.2) 0.002*
T 265 (12.6) 243 (9.8)
* Indicates significance: for genotypes: c
2 = 9.839, df = 2; for alleles:
c
2 = 9.075, df = 1, OR = 1.33, 95%CI: 1.108-1.604.
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(-1637T/C, -463T/C, -411C/T) as well as 3’UTR (939A/
G and 1097A/T) of HNMT gene have been also
reported [13], however their functionality has not been
well described yet. The region containing -411C/T poly-
morphism is located in a positive regulatory sequence
between nucleotides -493 and -395 [22]. For the other
SNPs, no data about their possible functionality are
available to our knowledge.
Among several ABP1 polymorphisms, one contribut-
ing to His645Asp substitution (rs1049793) was found to
be functional and was associated with significant
decrease in the serum enzyme activity in vivo [9]. In our
group we did not observe an association of this poly-
morphism with asthma, which is consistent with the
findings by Garcia-Martin et al. [19]. It is also note-
worthy, that enzyme activity may be influenced by other
ABP1 polymorphisms (eg. Thr16Met) and factors such
as gender, with enzyme activity being significantly
higher in healthy women in comparison to men, there-
fore ABP1 activity as a biological marker should be trea-
ted with cautious [23]. However, involvement of
His645Asp SNP in histamine metabolism cannot be
ignored and may be related to precise clinical phenotype
rather than asthma per se.
The main limitation of the present study was the small
sample size of the analyzed group. Our group (n = 149
asthmatic patients) is comparable to the group reported
by Garcia-Martin [19] (n = 159 asthmatic patients), but it
is smaller than the samples described by Sasaki et al. [17]
(n = 192 asthmatic Caucasian patients), Sharma et al.
[21] (n = 216 asthmatics) and Deindl [18] (n = 261 asth-
matics). Therefore, inconsistent results (at least for 314C/
T polymorphism of HNMT gene) might have arisen from
insufficient sample size and power which is further sup-
ported by our demonstration that increasing sample size
by combining data from different samples may be useful
in validating the existing results by increasing power.
Conclusions
In conclusion, we report here an association of HNMT
functional polymorphism with allergic asthma which
was further confirmed on a larger group of independent
studies. However, interpretation should be careful taking
into account the ethnic differences between analyzed
populations. Moreover, interactions with other poly-
morphisms associated with histamine metabolism (eg.
histidine decarboxylase gene, histamine receptors genes)
may influence the risk of asthma development.
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